Kung Winston 4

What Happened Winston Kung, a director of Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 2,026 shares on June 10, 2026. The Form 4 reports a weighted average sale price of $7.91 for aggregate proceeds of approximately $16,033. The sale was reported as an open market/private sale (Code S).

Key Details

• Transaction date: 2026-06-10; Form filed: 2026-06-11 (timely).
• Price: weighted average $7.91; underlying trade prices ranged $7.71–$7.97. Reporting person can provide per-price breakdown on request (Footnote F2).
• Proceeds: ~$16,033 for 2,026 shares sold.
• Plan/authorization: transaction effected pursuant to a Rule 10b5-1 trading plan adopted March 11, 2026 (Footnote F1).
• Holdings note: the reported ownership figure in the filing includes 3,800 unvested RSUs subject to vesting (Footnote F3).
• Filing accession: SEC Filing 0001193125-26-267672.

Context Sales executed under a 10b5-1 plan are pre-arranged and often scheduled in advance, which can limit what the sale implies about the insider’s view. This was a modest single sale by a director; retail investors should consider it as one data point and review the full Form 4 for additional ownership details.